CRISPR Therapeutics AG (CRSP) shares rallied 6.5% in the last trading session to close at $44.20. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Wealthfront was founded in 2008, offers a range of exchange-traded funds (ETFs) managed by other companies, and has more than $50 billion in assets under management (AUM). When ma ...
Because it's weighted by market cap, the fund's top holdings are identical to the Vanguard S&P 500 ETF's (all of the ...
21hon MSN
Abbott also is a buy for its dividend strength. As a Dividend King it's raised its dividend for more than 50 consecutive ...
MarketBeat on MSN18h
MaxCyte: Building the Future of Cell and Gene Therapy InnovationMaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback